ARCA BIOPHARMA INC (ABIO) Stock Balance Sheet
NASDAQ:ABIO - Nasdaq - US00211Y5069 - Common Stock - Currency: USD
| MRQ (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 33.28M | 37.43M | 42.45M | 53.36M | 49.10M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 537.00K | 161.00K | 254.00K | 1.06M | 900.00K | |||
| Total Current Assets | 33.82M | 37.59M | 42.70M | 54.42M | 50.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 12.00K | 257.00K | 368.00K | 485.00K | 400.00K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 12.00K | 12.00K | 18.00K | 18.00K | 0.00 | |||
| Total Non-Current Assets | 24.00K | 269.00K | 386.00K | 503.00K | 400.00K | |||
| TOTAL ASSETS | 33.84M | 37.86M | 43.09M | 54.92M | 50.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 700.00K | 275.00K | 798.00K | 2.38M | 1.70M | |||
| Accounts Payable | 571.00K | 362.00K | 334.00K | 1.12M | 1.80M | |||
| Total Current Liabilities | 1.27M | 637.00K | 1.13M | 3.50M | 3.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 204.00K | 280.00K | 383.00K | 400.00K | |||
| Total Non-Current Liabilities | 0.00 | 204.00K | 280.00K | 383.00K | 400.00K | |||
| TOTAL LIABILITIES | 1.27M | 841.00K | 1.41M | 3.88M | 3.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -193.43M | -188.74M | -183.40M | -173.48M | -154.20M | |||
| Additional Paid In Capital | 225.99M | 225.75M | 225.06M | 224.50M | 200.70M | |||
| Common Shares | 14.00K | 14.00K | 14.00K | 14.00K | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 14.51M | 14.50M | 14.41M | 14.41M | 9.50M | |||
| Tangible Book Value per Share | 2.25 | 2.55 | 2.89 | 3.54 | 4.89 | |||
| Total Shareholders' Equity | 32.57M | 37.02M | 41.67M | 51.04M | 46.50M | |||
| TOTAL LIABILITIES AND EQUITY | 33.84M | 37.86M | 43.09M | 54.92M | 50.40M | |||
| Statistics | ||||||||
| Current Ratio | 26.61 | 59.01 | 37.72 | 15.56 | 14.29 | |||
| Return On Assets (ROA) | -21.27% | -14.10% | -23.04% | -35.18% | -19.33% | |||
| Return On Equity (ROE) | -22.10% | -14.42% | -23.82% | -37.85% | -20.95% | |||
All data in USD , ROIC based on taxRate of 0.21